Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

Summary

The purpose of the study is to determine the comparative effectiveness of a provider-only intervention and a parent plus provider intervention to increase initiation of HPV vaccination among male and female patients ages 11-17 in a large pediatric clinic network in the greater Houston area. The hypothesis is that HPV vaccine initiation will be higher in clinics randomized to the parent plus provider intervention compared with clinics randomized to the provider-only intervention.

Conditions

• Human Papillomavirus (HPV)

Interventions

BEHAVIORAL

Provider assessment and feedback

Tailored immunization reports highlighting adolescent vaccination rates at the individual, clinic and network levels are distributed by clinic champions every quarter. Reports track vaccination rates over time and allow physicians to compare their rates to the national goal.

BEHAVIORAL

Provider reminders

An EHR-based reminder system informs providers when patients are due or overdue for HPV vaccination.

BEHAVIORAL

Provider education

Provider education is being delivered through a comprehensive online continuing education activity that is tailored specifically to physicians, nurses, and clinical staff at TCP practices. It focuses on HPV vaccination best practices and communicating with parents about the HPV vaccine.

BEHAVIORAL

Patient reminders

Patient reminders are delivered through MyChart, the clinics' online personal health record system, to inform patients (parents) that they are due or overdue for HPV vaccination.

BEHAVIORAL

Parent education

The parent education intervention (currently in development) will employ innovative strategies to identify and overcome barriers to HPV vaccination.

Sponsors & Collaborators

• Cancer Prevention Research Institute of Texas

  collaborator OTHER

• Baylor College of Medicine

  collaborator OTHER

• The University of Texas Health Science Center, Houston

  lead OTHER

Principal Investigators

• Sally W Vernon, PhD · The University of Texas Health Science Center, Houston

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

11 Years

Max Age

17 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2015-03-01

Primary Completion

2019-02-28

Completion

2019-02-28

Countries

• United States

Study Locations